Articles Referencing CPHD
Neutral Rating Restated for Cepheid - Analyst Blog
5/13/2013, 3:15 pm from Zacks.com in Investing, Business, Stocks
On May 9, 2013, we reaffirmed our long-term Neutral
recommendation on Cepheid ( CPHD ) following
strong first-quarter results. While the company continues to record
strong quarterly... Read >>
DexCom Loss Narrower than Est. - Analyst Blog
5/2/2013, 2:26 pm from Zacks.com in Investing, Business, Stocks
DexCom, Inc. ( DXCM ), a player in
the glucose monitoring market, reported first quarter 2013 adjusted
loss per share of 16 cents, narrower than the Zacks Consensus
Estimate of a loss of 17... Read >>
Huge Earnings Miss By AMED, Guides Low - Analyst Blog
5/1/2013, 3:38 pm from Zacks.com in Investing, Business, Earnings, Stocks
Home healthcare provider Amedisys ( AMED ) reported net
income of $3.9 million or 9 cents per share in the first quarter of
2013, a considerable slide from net income of $8.6 million... Read >>
ResMed's Earnings Beat; Revs Lag - Analyst Blog
4/29/2013, 2:50 pm from Zacks.com in Investing, Business, Earnings, Stocks
ResMed Inc. (RMD) posted adjusted earnings per share (EPS) of 59
cents in the third quarter of fiscal 2013, edging past the Zacks
Consensus Estimate by a couple of cents. The results were... Read >>
Weekly CEO Sells Highlight: SeaCube, Hasbro, Cepheid, Honeywell
4/28/2013, 9:59 pm from GuruFocus in Investing
According to GuruFocus Insider Data , these are the largest
CEO sales during the past week: SeaCube Container Leasing Ltd.,
Hasbro Inc., Cepheid and Honeywell International Inc. SeaCube... Read >>
Covidien Expands Shiley Offerings - Analyst Blog
4/19/2013, 3:50 pm from Zacks.com in Investing, Business, Stocks
International health care products major, Covidien
plc ( COV )
has expanded its portfolio of Shiley neonatal and pediatric
tracheostomy tubes with the launch of a new offering. The... Read >>
FDA Nod for Luminex Offering - Analyst Blog
4/19/2013, 2:10 pm from Zacks.com in Investing, Business, Stocks
Diagnostic testing technologies company, Luminex
Corporation ( LMNX ) has won
clearance from the U.S. Food and Drug Administration for its MAGPIX
instrument, with its xTAG Gastrointestinal... Read >>
Cepheid Earnings Beat, Retains Outlook - Analyst Blog
4/19/2013, 12:13 pm from Zacks.com in Investing, Business, Earnings, Stocks
Cepheid ( CPHD ) reported
first-quarter 2013 adjusted earnings of 2 cents per share,
significantly better than the Zacks Consensus Estimate of loss of 2
cents per share and loss of 10 cents... Read >>
New Patent for Biolase - Analyst Blog
4/18/2013, 4:12 pm from Zacks.com in Investing, Business, Stocks
Recently, dental lasers' manufacturer and distributor,
BIOLASE, Inc. ( BIOL ) was awarded a
new patent for its non-contact laser hand piece for tissue cutting
by the U.S. Patent and... Read >>
Volcano Corporation Stays Neutral - Analyst Blog
4/18/2013, 3:12 pm from Zacks.com in Investing, Business, Stocks
Recently, we have reaffirmed our Neutral recommendation on
Volcano Corporation ( VOLC ). Although we
are concerned about the company's disappointing fourth quarter 2012
and conservative... Read >>
Myriad Downgraded to Neutral - Analyst Blog
4/18/2013, 3:10 pm from Zacks.com in Investing, Business, Stocks
On Apr 17, we downgraded our recommendation on Myriad
Genetics Inc. ( MYGN ) to Neutral from
Outperform. Despite the recent healthy growth, the stock is
presently out of favor on account of... Read >>
Encouraging 4Q Prelims for Abiomed - Analyst Blog
4/18/2013, 2:09 pm from Zacks.com in Investing, Business, Stocks
Leading cardiac assist devices maker, Abiomed
Inc. ( ABMD ), provided
encouraging preliminary data for its fourth-quarter 2013 results.
The company will report full results on May 2, 2013. ... Read >>
Varian Applies Latest Vitesse - Analyst Blog
4/17/2013, 3:13 pm from Zacks.com in Investing, Business, Stocks
Oncology and X-Ray products company Varian Medical
Systems ( VAR ) recently revealed
that a patient with prostate cancer was the first to receive
therapy from the most current edition of... Read >>
More Backing for HOLX Tomosynthesis - Analyst Blog
4/17/2013, 3:10 pm from Zacks.com in Investing, Business, Stocks
Leading player in the women's health market Hologic
Inc. ( HOLX ) continues to
leap forward with positive data supporting the adoption of its
tomosynthesis technology. The company stated... Read >>
Another Earnings Miss for DGX - Analyst Blog
4/17/2013, 1:16 pm from Zacks.com in Investing, Business, Earnings, Stocks
Leading diagnostic testing company, Quest
Diagnostics ( DGX ) reported earnings
per share ("EPS") from continuing operations of 72 cents in the
first quarter of 2013, down... Read >>